All Cosmos Bio-Tech Holding Corp

All Cosmos Bio-Tech Holding Corp has a debt-to-equity ratio of 0.25, indicating a relatively conservative capital structure. The company's liquidity position is characterized as medium, with a current ratio of 3.42, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -17.88 million TWD, and its operating cash flow is 64.23 million TWD, indicating that capital expenditures are outpacing operating cash flow.

In terms of profitability, the company's return on equity is 1.27%, and its return on assets is 0.77%, both of which are below the industry median for Agricultural Chemicals. This suggests that the company is underperforming its peers in terms of generating returns for shareholders and utilizing its assets efficiently.

The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to higher risk if demand for its products in its primary market declines.

Looking at the company's growth trajectory, there is no specific outlook provided for the current or next fiscal year. However, the company's capital expenditures of -71.16 million TWD indicate a significant investment in infrastructure, which could support future growth. The company's operating income of 23.77 million TWD and net income of 28.49 million TWD suggest a modest profit margin, which may limit its ability to reinvest in growth initiatives.

The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of net cash being negative after subtracting total debt highlights a potential liquidity constraint. The company's dilution potential is low, as there is no indication of share issuance or other dilutive events in the near term.

Recent events and filings do not provide specific details on the company's operations or strategic initiatives. The company's financial statements and risk assessment suggest a stable but not particularly dynamic business environment. There are no recent transcripts or filings that indicate significant changes in the company's business strategy or financial position.

Free cash flow surged 784.8% year-over-year to TWD 196.3 million, demonstrating significant improvement in cash generation capabilities.

Operating income jumped 84.4% year-over-year to TWD 296.7 million, indicating strong operational leverage and cost management efficiency.

Cash conversion ratio of 2.25 exceeds the agricultural chemicals cohort median of 0.9, highlighting superior earnings quality.

Debt-to-equity ratio of 0.25 is below the cohort median of 0.34, suggesting a conservative capital structure with lower financial risk.

Revenue grew 19.9% year-over-year to TWD 2.95 billion, showing top-line expansion despite recent volatility in prior periods.

Return on equity of 1.27% is significantly below the cohort median of 5.24%, indicating poor capital efficiency relative to peers.

The company faces high credit risk, which could impair financial stability and increase borrowing costs in the future.

Net income CAGR of -6.3% over four years indicates a long-term decline in profitability despite recent quarterly improvements.

Revenue TWD 710.4M; Operating income TWD 42.8M.

• ▍Revenue TWD 710.4M
• ▍Operating income TWD 42.8M
• ▍Net margin 2.8%

Revenue TWD 746.3M; Operating income TWD 89.1M.

• ▍Revenue TWD 746.3M
• ▍Operating income TWD 89.1M
• ▍Net margin 9.7%

Revenue TWD 478.4M; Operating income TWD 5.3M.

• ▍Revenue TWD 478.4M
• ▍Operating income TWD 5.3M
• ▍Net margin 1.7%

Revenue TWD 523.5M; Operating income TWD 23.8M.

• ▍Revenue TWD 523.5M
• ▍Operating income TWD 23.8M
• ▍Net margin 5.4%

Revenue TWD 2.46B, −13,0% YoY; Operating income −15,3% YoY.

• ▍Revenue TWD 2.46B, −13,0% YoY
• ▍Operating income −15,3% YoY
• ▍Net income −7,7% YoY
• ▍Free cash flow +126,1% YoY
• ▍Net margin 5.2%

Revenue TWD 2.83B, −23,6% YoY; Operating income −71,5% YoY.

• ▍Revenue TWD 2.83B, −23,6% YoY
• ▍Operating income −71,5% YoY
• ▍Net income −62,1% YoY
• ▍Free cash flow −124,4% YoY
• ▍Net margin 4.9%

Revenue TWD 3.70B, +68,5% YoY; Operating income +144,1% YoY.

• ▍Revenue TWD 3.70B, +68,5% YoY
• ▍Operating income +144,1% YoY
• ▍Net income +85,8% YoY
• ▍Free cash flow +196,6% YoY
• ▍Net margin 9.9%

Revenue TWD 2.20B; Operating income TWD 273.2M.

• ▍Revenue TWD 2.20B
• ▍Operating income TWD 273.2M
• ▍Net margin 9.0%